On Demand Education

Recent developments in prognostic and predictive testing in uveal melanoma.

May 2014

Curr Opin in Ophthalmol 2014;25(3):234-9.

Field MG & Harbour JW.

Instrument gauge and type in uveal melanoma fine needle biopsy: implications for diagnostic yield and molecular prognostication.

Aug 2020

Am J Ophthalmol 2020; online ahead of print.

Klofas LK, Bogan CM, Coogan A, et al.

Collaborative Ocular Oncology Group Report Number 1: Prospective validation of a multi-gene prognostic assay in uveal melanoma.

Aug 2012

Ophthalmology 2012;119: 1596-1603.

Onken MD, Worley LA, Char CH, et al

An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Jul 2010

J Mol Diagn 2010;12(4):461-8.

Onken MD, Worley LA, Tuscan MD, et al.

Prognostic testing in uveal melanoma by transcriptomic profiling of fine needle biopsy specimens.

Nov 2006

J Mol Diagn 2006;8:567-73.

Onken MD, Worley LA, Davila RM, et al.

Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics.

Diagn Pathol 2017;12(1):59.

Plasseraud KM, Wilkinson JK, Oelschlager KM, et al.

Clinical performance and management outcomes with the DecisionDx-UM gene expression profile test in a prospective multicenter study.

Jun 2016

 J Oncol 2016; doi:10.1155/2016/5325762.

Plasseraud KM, Cook RW, Tsai T, et al.

Prospective evaluation of risk-appropriate management of uveal melanoma patients informed by gene expression profiling.

Mar 2020

Melanoma Manag 2020;7(1):MMT37.

Schefler AC, Skalet A, Oliver SCN, et al.

PRAME as an independent biomarker for metastasis in uveal melanoma.

Mar 2016

Clin Cancer Res 2016;22(5):1234-42.

Field MG, Decatur CL, Kurtenbach S, et al.

Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.

Apr 2011

 J Med Genet 2011;48:856-9.

Abdel-Rahman MH, Pilarski R, Cebulla CM, et al.

Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes.

Jul 2016

 JAMA Ophthalmol 2016;134:728-33.

Decatur CL, Ong E, Garg N, et al.

Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.

Aug 2014

Invest Ophthalmol Vis Sci 2014;55:5160-7.

Ewens KG, Kanetsky PA, Richards-Yutz J, et al.